Litigation Details for Braintree Laboratories, Inc. v. Taro Pharmaceuticals USA, Inc. (S.D.N.Y. 2014)

Braintree Laboratories, Inc. v. Taro Pharmaceuticals USA, Inc. (S.D.N.Y. 2014)

Docket		Date Filed	2014-10-09
Court	District Court, S.D. New York	Date Terminated	2016-11-14
Cause	35:271 Patent Infringement	Assigned To	Alison Julie Nathan
Jury Demand	None	Referred To
Patents	6,946,149
Firms	Winston & Strawn LLP (IL)
Link to Docket	External link to docket

Details for Braintree Laboratories, Inc. v. Taro Pharmaceuticals USA, Inc. (S.D.N.Y. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-01-15	15		This is a patent infringement action under the Hatch-Waxman Act. The case concerns U.S. Patent No. 6,946,149…“the ʼ149 patent”) and Braintree’s SUPREP® Bowel Prep Kit (“SUPREP”). The ʼ149 patent is listed …ʼ149 patent. There are currently three other pending litigations involving the ʼ149 patent and…claims of the ʼ149 patent (Novel D.N.J. Dkt. No. 261 at 18), and ruled that the ʼ149 patent is valid (Novel… in the present case, because the same patent (the ʼ149 patent) and the same or substantially the same	External link to document
2015-01-19	16		Braintree Laboratories, Inc.’s U.S. Patent No. 6,946,149 (the ‘ 149 patent) at issue in these four actions… currently two other actions involving the same patent at issue in this and the Breckenrz'dge actions…the issues in the present case, because the same patent and the same or substantially the same drugs are… 15 November 2016 1:14-cv-08147 830 Patent None District Court, S.D. New York	External link to document
2015-06-16	21		claims 19, 20, and 23, of U.S. Patent Number 6,946,149 (the “’149 Patent”). Novel filed a notice of appeal…the issues in the present case, because the same patent and the same or substantially the same drugs are… 15 November 2016 1:14-cv-08147 830 Patent None District Court, S.D. New York	External link to document